Katherine Kruse, MD

Specialty: Pediatric Critical Care

Education

Fellowship

  • Pediatric Critical Care Medicine, Lucile Packard Children’s Hospital Stanford, Stanford University School of Medicine – Stanford, CA
  • Clinical Ethics, Stanford University School of Medicine – Stanford, CA

Internship/Residency

  • Intern, Pediatrics, Michigan State University — East Lansing, MI (2010-2011)
  • Resident, Pediatrics, Michigan State University — East Lansing, MI (2011-2013)

Medical school

  • Doctor of Medicine, Michigan State University — Grand Rapids, MI (2006-2010)

Undergraduate

  • Bachelor of Science, Michigan State University – Grand Rapids, MI (2001-2005)

Professional Interests

  • Sepsis
  • ECMO
  • Palliative care
  • Clinical ethics

Board Certification

  • General Pediatrics
  • Pediatrics, Critical Care Medicine

Publications

  • Rajasekaran S, Kruse KE, Kovey K, Davis A, Hassan N, Ndika A, Zuiderveen S, Birmingham J “Therapeutic Role of Anakinra, an Interleukin-1 Receptor Antagonist, in the Management of Secondary Hemophagocytic Lymphohistiocytosis/Sepsis/Multiple Organ Dysfunction/Macrophage Activating Syndrome in Critically Ill Children.” Pediatr Crit Care Med. 2014 June;15(5):401-408. PMID: 24583503
  • Burgart AM, Kruse KE; “Moral Distress in Clinical Ethics: Expanding the Concept.” American Journal of Bioethics. December 2016. PMID: 27901425
  • Kruse KE, Purohit P, Ross C, Su F, Aghaeepour N, Hammer GB; “The Incidence of Subglottic Stenosis Following Cardiac Surgery with Cardiopulmonary Bypass in Infants and Children.” In Press. Pediatr Crit Care Med. PMID: 28277376
  • Kreitmar K, Kruse KE; “Practical Implications of a Minimally Conscious State Diagnosis. In Press. Clinical Neuroethics. Vol 26, No 4, October, 2017. PMID: 28937345
  • Challenges to code status discussions for pediatric patients
    Kruse KE, Batten J, Constantine ML, Kache S, Magnus D (2017) Challenges to code status discussions for pediatric patients. PLOS ONE 12(11): e0187375. https://doi.org/10.1371/journal.pone.0187375
  • Batten JN, Kruse KE, Kraft SA, Fishbeyn B, Magnus DC. “What Does the Word “Treatable” Mean? Implication for Communication and Decision-Making in Critical Illness.” Crit Care Med. Dec 2018. PMID: 30585833

Personal Bio

Dr. Katie Kruse was born and raised in Michigan where she completed both her undergraduate and medical school degrees from Michigan State University (MSU). From there she did her pediatric residency through MSU at Helen DeVos Children’s Hospital in Grand Rapids, MI. She then moved to California where she completed her critical care training at Stanford, with further fellowship training in clinical ethics at the Stanford Center for Biomedical Ethics. Research interest include communication and decision-making at the end of life for pediatric patients. Her areas of interest include ECMO, sepsis, palliative care, and ethical consideration in pediatrics.